問卷

TPIDB > Principal Investigator

Principal Investigator


China Medical University Hospital (在職)

Division of Neurology

更新時間:2023-09-19

敖瑀Ao, Yu
  • Co-Principal Investigator
  • Clinical Trial Experience (year) 7 years 9 個月

篩選

List

11Cases

2018-02-01 - 2024-12-31

Phase II

Active
A Randomized, Double Blinded, Placebo-controlled Phase II Study to Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia
  • Condition/Disease

    Parkinson′s disease dementia

  • Test Drug

    ceftriaxone

Participate Sites
11Sites

Recruiting5Sites

Terminated5Sites

2024-03-01 - 2026-03-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Not yet recruiting1Sites

Recruiting4Sites

2020-04-01 - 2027-12-31

Phase I

Active
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2023-12-21 - 2028-01-21

Phase II/III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting7Sites

2024-01-25 - 2029-01-31

Phase III

Active
A 52-Week, Open-Label Extension Study of ACP-204 in Adults with Alzheimer’s Disease Psychosis
  • Condition/Disease

    Alzheimer’s Disease Psychosis

  • Test Drug

    tablets

Participate Sites
7Sites

Recruiting7Sites

2025-12-01 - 2028-06-30

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

2020-04-01 - 2025-12-31

Phase I

A phase I, open label study to evaluate the safety and to explore the efficacy of allogeneic umbilical cord mesenchymal stem cells in patients with acute ischemic stroke
  • Condition/Disease

    acute ischemic stroke

  • Test Drug

    UMSC01

Participate Sites
2Sites

Recruiting2Sites

1 2